|
Match
|
Document |
Document Title |
|
|
7138133 |
Orally administered liquid compositions
The present invention is an orally administered liquid pharmaceutical composition that demonstrates excellent physical stability while delivering concentrated levels of the pharmaceutical...
|
|
|
7094429 |
Process for preparing tannate liquid and semi-solid dosage forms
An active ingredient from the group of an antihistamine, a decongestant, an antitussive or anticholinergic is dissolved in a suitable solvent and added to a dispersion of tannic acid in water to...
|
|
|
6939856 |
Method for preparing dexchlor tannate
The invention pertains to a method for preparing dexchlorpheniramine (“dexchlor”) tannate by reacting dexchlorpheniramine free base at a temperature of about 75 to about 150° C. with tannic...
|
|
|
6869618 |
Process for preparing tannate liquid and semi-solid dosage forms
An active ingredient from the group of an antihistamine, a decongestant, an antitussive or anticholinergic is dissolved in a suitable solvent and added to a dispersion of tannic acid in water to...
|
|
|
6790849 |
Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants
Methods and pharmaceutical compositions employing (+) cetirizine, (−) cetirizine, or racemic cetirizine, or a pharmaceutically acceptable salt thereof, and a leukotriene inhibitor, or a...
|
|
|
6670370 |
Dextromethorphan tannate
The invention pertains to a composition comprising dextromethorphan tannate and to a method for preparing dextromethorphan tannate by reacting dextromethorphan at a temperature of about 80 to about...
|
|
|
6566396 |
Antitussive/antihistaminic compositions
Tannate compositions consisting essentially of carbetapentane tannate and chlorpheniramine tannate which are effective when administered orally for the symptomatic relief of coryza associated with...
|
|
|
6384038 |
Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
Methods and pharmaceutical compositions employing (+) cetirizine, (−) cetirizine, or racemic cetirizine, or a pharmaceutically acceptable salt thereof, and a leukotriene inhibitor, or a...
|
|
|
6362197 |
Compositions and method for treatment of cough
Pharmaceutical compositions possessing anti-tussive activity, and a method of administering the same to warm-blooded animals, including humans.
|
|
|
6335030 |
Transdermally administered dextromethorphan as antitussive agent
The present invention is drawn to a device for the transdermal administration of dextromethorphan, (+)-3-methoxy-17-methyl-9a,13a,14a-morphanin, and salts, prodrugs and metabolites thereof,...
|
|
|
6211152 |
Formulations for peptide release
A pharmaceutical and/or veterinary formulation comprising deslorelin and an excipient, the formulation being characterised in that, in vitro, it releases deslorelin into phosphate buffered saline,...
|
|
|
6194460 |
Composition for treating cough induced by angiotensin converting enzyme inhibitors
The claims define a method which is based on the use of baclofen to suppress the cough of a patient who is afflicted with a cough that is induced by the administration of an ACE inhibitor. The...
|
|
|
6121290 |
Use of GABA uptake inhibitors as anti-tussive agents
Invention is a method of treating cough in a mammal, including a human, which comprises administering to such mammal an effective amount of an inhibitor of GABA uptake.
|
|
|
6001392 |
Antitussive drugs delivered by ion exchange resins
The present invention relates generally to a mixture of coated and non-coated sulfonic acid cation exchange resins (Amberlite IR69) cross-linked with about 8% divinyl benzene onto which...
|
|
|
5932589 |
Antitussive composition containing dextromethorphan and benzydamine
Oral antitussive pharmaceutical composition which allows a significant contact of its components with mucous membranes of the buccal cavity and comprises a centrally acting antitussive or a...
|
|
|
5760085 |
Topical aromatic releasing compositions
The present invention relates to topical aromatic releasing compositions containing one or more volatile aromatic compounds selected from the group consisting of 3-1-menthoxy propane-1,2-diol,...
|
|
|
5730997 |
Tastemasked liquid pharmaceutical delivery system
A substantially tasteless liquid phramaceutical delivery system containing an active material and a high osmolarity aqueous system comprising (i) water; (ii) about 20% to about 45% by weight sugar...
|
|
|
5534552 |
Clear non-alcoholic sinus and allergy medication
A clear, hypoallergenic sinus and allergy medication is orally administered in an aqueous, liquid dosage form. The formulation provides effective sinus and allergy relief without alcohol or dyes...
|
|
|
5514665 |
Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
Methods for reducing the risk of or preventing infections by bacterial pathogens in vivo. In particular, a method for reducing the risk of P. aeruginosa infection in vivo in compromised hosts such...
|
|
|
5422357 |
Method of using oxatomide as antitussive agent
Oxatomide reduces the number of cough attacks and also prolongs the time between each attack. The effect is dose-related.
|
|
|
5409907 |
Aqueous pharmaceutical suspension for pharmaceutical actives
The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a...
|
|
|
5352703 |
Antitussive and mucus regulating agent, a process for the preparation thereof and pharmaceutical compositions containing it
2-benzoylamino-3,5-dibromo-N-(4-hydroxycyclohexyl)benzylamin
e of formula (I), and pharmaceutically acceptable acid addition salts have antitussive and mucus regulating activities. ##STR1##
|
|
|
5223541 |
Tramadol N-oxide material, enantiomers and compositions thereof, and their use
This invention relates to a tramadol N-oxide material, enantiomers and compositions thereof and their use. The tramadol N-oxide material and compositions thereof are pharmacologically useful in...
|
|
|
5100898 |
Antitussive liquid compositions containing dyclonine
Novel antitussive and anesthetic liquid compositions of matter for oral use comprising an effective oral antitussive drug and dyclonine; and method of using same.
|
|
|
5013554 |
Oral pharmaceutical compositions containing dextrophan salts
Dextrorphan salts with polycarboxylic organic acids are effectively absorbed by the oral route and can conveniently be formulated in pharmaceutical compositions suitable to the oral administration.
|
|
|
5006560 |
Use of GABA-B selective agonists as anti-tussive agents
A method for treating cough in a mammal comprising administering to said mammal an anti-tussive effective amount of a GABA-B selective agonist such as ##STR1## is described.
|
|
|
4971798 |
Hard confections containing hydrogenated isomaltulose and medicinally active ingredient
Disclosed is a hard confection containing Palatinit (hydrogenated isomaltulose) and a medicinally active ingredient. Such a formulation has been found to dissolve more slowly than similar...
|
|
|
4892877 |
Antitussive liquid compositions containing phenol
Novel antitussive and anesthesic liquid compositions of matter for oral use comprising an effective oral antitussive drug and phenol, and method of using same.
|
|
|
4788055 |
Resinate sustained release dextromethorphan composition
A pharmaceutical preparation for controlled, sustained release of dextromethorphan comprising a polystyrene sulfonate resin which has been cross-linked with about 3% to about 10% divinyl benzene,...
|
|
|
4775694 |
Antitussive composition
The invention relates to an oral pharmaceutical composition containing benzonatate. More particularly it concerns a composition of this character having improved taste and demulcency...
|
|
|
4767612 |
Triamcinolone acetonide for the treatment of allergic rhinitis
Disclosed is a method for the treatment of allergic rhinitis that manifests itself as rhinorrhea, nasal itching, sneezing, congestion and postnasal drip. The method comprises the administration...
|
|
|
4762719 |
Powder filled cough product
A cough drop is provided comprising a hard candy outer shell and a powdered centerfill containing a rapidly-dissolving powder such as dextrose monohydrate and an active ingredient such as menthol...
|
|
|
4650663 |
Magnesium trisilicate suitable for preparation of medicament adsorbates of antitussives
A medicament adsorbate containing a magnesium trisilicate having a surface area of at least 400 m 2 /g and having a flake-like structure with multiple interstitial spaces, and having adsorbed...
|
|
|
4461895 |
Dibenzo(de,g)quinolines
The present invention provides dibenzo(de,g)quinoline derivatives of the general formula: ##STR1## wherein R is an unsaturated aliphatic hydrocarbon radical containing up to 6 carbon atoms or a...
|
|
|
4454140 |
Nasal administration of dextromethorphan
The invention relates to a novel method of administering dextromethorphan, a known anti-tussive agent used for the suppresion of coughs due to colds and allergies. The novel method utilizes dosage...
|
|
|
4427681 |
Thixotropic compositions easily convertible to pourable liquids
Compositions employing titanium dioxide as an opacifying agent and which are thixotropic gels easily convertible to pourable liquids with moderate shaking are provided by employing Avicel® RC-591...
|
|
|
4401672 |
Non-addictive narcotic antitussive preparation
Non-addictive narcotic antitussive preparations including a normally addictive narcotic analgesic cough suppressive agent and a highly selective long-acting narcotic antagonist in a...
|
|
|
4378359 |
Theophyllinylmethyldioxolane derivatives, methods for their preparation and pharmaceutical compositions containing them
Compounds of the following general formula ##STR1## wherein: X and Y are different from each other and represent --CH 2 -- or an oxygen atom; R represents a radical selected from hydroxy, bromo,...
|
|
|
4353914 |
Antitussive anilides
The invention relates to novel antitussive anilides and non-toxic acid addition salts thereof. These novel compounds have the general formula ##STR1## wherein n is an integer from 2 to 3, and...
|
|
|
4351833 |
9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics
9-Amino-1-hydroxyoctahydrobenzo[c]quinoline derivatives of formula ##STR1## and pharmaceutically acceptable acid addition salts thereof wherein R is hydrogen, COR 7 or SO 2 R 8 where R 7 is...
|
|
|
3914425 |
Antitussive codeine composition
The antitussive effect of codeine, orally administered in the form of its pharmaceutically acceptable salts, is enhanced by the simultaneous administration of acid addition salts of heptaminol...
|
|
|
3789125 |
PHARMACEUTICAL COMPOSITIONS CONTAINING HALO-SUBSTITUTED 2-AMINO-BENZYLAMINE-AMIDES
Antitussive and respiration-stimulating pharmaceutical compositions containing as an active ingredient a compound of the formula ##SPC1## Wherein Hal is chlorine or bromine, R 1 is hydrogen,...
|
|
|
3679799 |
PIPERDINE DERIVATIVES IN AN ANTITUSSIVE COMPOSITION AND METHOD
Piperidine derivatives with a cyano group in four-position and acid addition salts thereof possessing useful antitussive action; therapeutic compositions containing these piperidine derivatives or...
|
|
|
3511915 |
METHOD OF PRODUCING AN ANTITUSSIVE EFFECT
|
|
|
3509258 |
THERAPEUTIC COMPOSITIONS CONTAINING PIPERIDINE DERIVATIVES AND METHODS OF TREATING COUGH THEREWITH
|
|
|
3446799 |
NOVEL PYRIDO(2,3-B)(1,5)BENZOOXAZEPIN-5-ONES AND PYRIDO(2,3-B)(1,5)BENZOTHIAZEPIN-5-ONES
|
|
|
3408446 |
SUPPRESSING COUGHS AND INCREASING SECRETIONS IN WARM-BLOODED ANIMALS WITH N-(AMINO-3,5-DIHALOBENZYL)-CAMPHIDINES
|
|
|
3313686 |
Palatable antitussive agent-resin complex
|
|
|
3244588 |
Method of inhibiting cough with thiaxanthenol derivatives
|
|
|
2808360 |
Compositions for combatting cough
|